AdaptHealth Share Holder Equity 2018-2025 | AHCO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AdaptHealth share holder equity from 2018 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AdaptHealth share holder equity from 2018 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$219.8B
Boston Scientific (BSX)	$156.6B
Stryker (SYK)	$152.9B
EssilorLuxottica (ESLOY)	$137.9B
Medtronic (MDT)	$118B
Lonza Group Ag (LZAGY)	$49.3B
Haleon (HLN)	$43.6B
ResMed (RMD)	$40.1B
GE HealthCare Technologies (GEHC)	$35.6B
Agilent Technologies (A)	$34B
Terumo (TRUMY)	$25.6B
Koninklijke Philips (PHG)	$24.7B
Insulet (PODD)	$20.6B
Zimmer Biomet Holdings (ZBH)	$19B
Baxter (BAX)	$14.6B
Smith & Nephew SNATS (SNN)	$13.7B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$6.9B
Lantheus Holdings (LNTH)	$5B
Perrigo (PRGO)	$3.9B
Prestige Consumer Healthcare (PBH)	$3.8B
Haemonetics (HAE)	$3.6B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
ICU Medical (ICUI)	$3.1B
LeMaitre Vascular (LMAT)	$1.9B
QuidelOrtho (QDEL)	$1.8B
AtriCure (ATRC)	$1.6B
Acuren (TIC)	$1.4B